Table 3.

Changes made to patients' treatment according to lung cancer stage (information on stage was missing for four patients)

Change to treatment	Stage I–II (n = 897)	Stage III (n = 645)
Any change	260 (29%)	265 (41.1%)
Change to radiotherapy dose/fractionation	144 (16.1%)	126 (19.5%)
Radiotherapy given instead of surgery	85 (9.5%)	18 (2.8%)
Chemotherapy dose reduced	12 (1.3%)	59 (6.8%)
Chemotherapy omitted	9 (1%)	69 (10.7%)
Immunotherapy dose reduced or omitted	0	8 (1.2%)
Watch and wait	31 (3.5%)	2 (0.3%)
Best supportive care	1 (0.1%)	2 (0.3%)
Other	2 (0.2%)	4 (0.6%)